当前位置: X-MOL首页全球导师 海外导师 › Gillespie, Stephen

近期论文

查看导师最新文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

Boeree, MJ, Heinrich, N, Aarnoutse, R, Diacon, AH, Dawson, R, Rehal, S, Kibiki, GS, Churchyard, G, Sanne, I, Ntinginya, NE, Minja, LT, Hunt, RD, Charalambous, S, Hanekom, M, Semvua, HH, Mpagama, SG, Manyama, C, Mtafya, B, Reither, K, Wallis, RS, Venter, A, Narunsky, K, Mekota, A, Henne, S, Colbers, A, Plemper van Balen, G, Gillespie, SH, Phillips, PPJ & Hoelscher, M 2017, 'High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial' Lancet Infectious Diseases, vol 17, no. 1, pp. 39-49. DOI: 10.1016/S1473-3099(16)30274-2, 10.1016/S1473-3099(16)30274-2 Muliaditan, M, Davies, GR, Simonsson, USH, Gillespie, SH & Pasqua, OD 2016, 'The implications of model–informed drug discovery and development for tuberculosis' Drug Discovery Today, vol In press. DOI: 10.1016/j.drudis.2016.09.004 Sabiiti, W, Mtafya, B, Kuchaka, D, Azam, K, Viegas, S, Mdolo, A, Farmer, E, Khonga, M, Evangelopoulos, D, Honeyborne, I, Rachow, A, Heinrich, N, Ntinginya, NE, Bhatt, N, Davies, GR, Jani, IV, McHugh, TD, Kibiki, G, Hoelscher, M, Gillespie, SH & on behalf of the PANBIOME (Pan-African Biomarker Expansion Programme) consortium 2016, 'Optimising molecular diagnostic capacity for effective control of tuberculosis in high-burden settings' International Journal of Tuberculosis and Lung Disease, vol 20, no. 8, pp. 1004-1009. DOI: 10.5588/ijtld.15.0951 Lipworth, S, Hammond, RJH, Baron, VO, Hu, Y, Coates, A & Gillespie, SH 2016, 'Defining dormancy in mycobacterial disease' Tuberculosis, vol 99, pp. 131-142. DOI: 10.1016/j.tube.2016.05.006 Boeree, MJ, Gillespie, SH, Hoelscher, M & PanACEA core team 2016, 'Therapy for Tuberculous Meningitis' New England Journal of Medicine, vol 374, no. 22, pp. 2187-8. DOI: 10.1056/NEJMc1602291#SA2 Honeyborne, I, McHugh, TD, Kuittinen, I, Cichonska, A, Evangelopoulos, D, Ronacher, K, van Helden, PD, Gillespie, SH, Fernandez-Reyes, D, Walzl, G, Rousu, J, Butcher, PD & Waddell, SJ 2016, 'Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy' BMC Medicine, vol 14, no. 1, pp. 1-13. DOI: 10.1186/s12916-016-0609-3 Phillips, PPJ, Dooley, KE, Gillespie, SH, Heinrich, N, Stout, JE, Nahid, P, Diacon, AH, Aarnoutse, RE, Kibiki, GS, Boeree, MJ & Hoelscher, M 2016, 'A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP)' BMC Medicine, vol 14, 51, pp. 1-11. DOI: 10.1186/s12916-016-0597-3 Gillespie, SH 2016, 'The role of moxifloxacin in tuberculosis therapy' European Respiratory Review, vol 25, no. 139, pp. 19-28. DOI: 10.1183/16000617.0085-2015 Phillips, PPJ, Mendel, CM, Burger, DA, Crook, AM, Nunn, AJ, Dawson, R, Diacon, AH & Gillespie, SH 2016, 'Erratum to: Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials: limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials' BMC Medicine, vol 14, 36. DOI: 10.1186/s12916-016-0585-7 Phillips, PPJ, Mendel, CM, Burger, DA, Crook, A, Nunn, AJ, Dawson, R, Diacon, AH & Gillespie, SH 2016, 'Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials' BMC Medicine, vol 14, 19, pp. 1-11. DOI: 10.1186/s12916-016-0565-y Donald, I, Meyer, K, Gillespie, SH, Bowness, R & Brengman, J 2015, Project Sanitarium: gaming TB - A serious game for a serious problem. in 7th International Conference on Games and Virtual Worlds for Serious Applications, VS-Games 2015., 7295782, IEEE, Seventh International Conference on Virtual Worlds and Games for Serious Applications: VS-Games 2015, University of Skövde, Sweden, 16-18 September. DOI: 10.1109/VS-GAMES.2015.7295782 Boeree, MJ, Diacon, AH, Dawson, R, Narunsky, K, du Bois, J, Venter, A, Phillips, PPJ, Gillespie, SH, McHugh, TD, Hoelscher, M, Heinrich, N, Rehal, S, van Soolingen, D, van Ingen, J, Magis-Escurra, C, Burger, D, Plemper van Balen, G & Aarnoutse, RE 2015, 'A Step toward an Optimized Rifampin Dose Completed' American Journal of Respiratory and Critical Care Medicine, vol 192, no. 4, pp. 525-6. DOI: 10.1164/rccm.201506-1061LE Hammond, RJH, Baron, VO, Oravcova, K, Lipworth, S & Gillespie, SH 2015, 'Phenotypic resistance in mycobacteria: is it because I am old or fat that I resist you?' Journal of Antimicrobial Chemotherapy, vol Advance Access. DOI: 10.1093/jac/dkv178 Honeyborne, I, Lipman, MC, Eckold, C, Evangelopoulos, D, Gillespie, SH, Pym, A & McHugh, TD 2015, 'Effective anti-tuberculosis therapy correlates with plasma small RNA' European Respiratory Journal, vol 45, no. 6, pp. 1741-1744. DOI: 10.1183/09031936.00221214 Boeree, MJ, Diacon, AH, Dawson, R, Narunsky, K, du Bois, J, Venter, A, Phillips, PPJ, Gillespie, SH, Mc Hugh, TD, Hoelscher, M, Heinrich, N, Rehal, S, van Soolingen, D, van Ingen, J, Magis-Escurra, C, Burger, D, Plemper van Balen, G & Aarnoutse, RE 2015, 'A dose ranging trial to optimize the dose of Rifampin in the treatment of tuberculosis' American Journal of Respiratory and Critical Care Medicine, vol 191, no. 9, pp. 1058-1065. DOI: 10.1164/rccm.201407-1264OC Gillespie, SH, Mendel, CM, Phillips, PPJ & REMoxTB Consortium 2015, 'Shorter moxifloxacin-based regimens for drug-sensitive tuberculosis' New England Journal of Medicine, vol 372, no. 6, pp. 577-577. DOI: 10.1056/NEJMc1414718 Gillespie, SH, Ling, CL, Oravcova, K, Pinheiro, M, Wells, L, Bryant, JM, McHugh, TD, Bébéar, C, Webster, D, Harris, SR, Seth-Smith, HMB & Thomson, NR 2015, 'Genomic investigations unmask Mycoplasma amphoriforme, a new respiratory pathogen' Clinical Infectious Diseases, vol 60, no. 3, pp. 381-388. DOI: 10.1093/cid/ciu820 Bowness, R, Boeree, MJ, Aarnoutse, R, Dawson, R, Diacon, A, Mangu, C, Heinrich, N, Ntinginya, NE, Kohlenberg, A, Mtafya, B, Phillips, PPJ, Rachow, A, Plemper van Balen, G & Gillespie, SH 2015, 'The relationship between Mycobacterium tuberculosis MGIT time to positivity and cfu in sputum samples demonstrates changing bacterial phenotypes potentially reflecting the impact of chemotherapy on critical sub-populations' Journal of Antimicrobial Chemotherapy, vol 70, no. 2, pp. 448-455. DOI: 10.1093/jac/dku415 Heinrich, N, Dawson, R, du Bois, J, Narunsky, K, Horwith, G, Phipps, AJ, Nacy, CA, Aarnoutse, RE, Boeree, MJ, Gillespie, SH, Venter, A, Henne, S, Rachow, A, Phillips, PPJ, Hoelscher, M, Diacon, AH & on behalf of the Pan African Consortium for the Evaluation of Antituberculosis Antibiotics (PanACEA) 2015, 'Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients' Journal of Antimicrobial Chemotherapy. DOI: 10.1093/jac/dku553 Hu, Y, Liu, A, Menendez, MC, Garcia, MJ, Oravcova, K, Gillespie, SH, Davies, GR, Mitchison, DA & Coates, ARM 2015, 'HspX knock-out in Mycobacterium tuberculosis leads to shorter antibiotic treatment and lower relapse rate in a mouse model - A potential novel therapeutic target' Tuberculosis, vol 95, no. 1, pp. 31-36. DOI: 10.1016/j.tube.2014.11.002 Gillespie, SH, Oravcova, K & Monnier Hovell, Z, Respiratory Mycoplasma Infections, 2015, Digital or Visual Products, Henry Stewart, Online. Gillespie, SH, Crook, AM, McHugh, TD, Mendel, CM, Meredith, SK, Murray, SR, Pappas, F, Phillips, PPJ & Nunn, AJ 2014, 'Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis' New England Journal of Medicine, vol 371, no. 17, pp. 1577-1587. DOI: 10.1056/NEJMoa1407426 Ling, CL, Oravcova, K, Beattie, TF, Creer, DD, Dilworth, P, Fulton, NL, Hardie, A, Munro, M, Pond, M, Templeton, K, Webster, D, Workman, S, McHugh, TD & Gillespie, SH 2014, 'Tools for detection of Mycoplasma amphoriforme: a primary respiratory pathogen?' Journal of Clinical Microbiology, vol 52, no. 4, pp. 1177-1181. DOI: 10.1128/JCM.03049-13 Zumla, AI, Gillespie, SH, Hoelscher, M, Philips, PPJ, Cole, ST, Abubakar, I, McHugh, TD, Schito, M, Maeurer, M & Nunn, AJ 2014, 'New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects' Lancet Infectious Diseases, vol 14, no. 4, pp. 327-40. DOI: 10.1016/S1473-3099(13)70328-1 Grossman, RF, Hsueh, P-R, Gillespie, SH & Blasi, F 2014, 'Community-acquired pneumonia and tuberculosis: differential diagnosis and the use of fluoroquinolones' International Journal of Infectious Diseases, vol 18, no. 1, pp. 14-21. DOI: 10.1016/j.ijid.2013.09.013

推荐链接
down
wechat
bug